Inhibition of Aggregation of Aluminum Hydroxide Adjuvant During Freezing and Drying

Aluminum-salt adjuvants are widely used to increase immunogenicity of recombinant protein vaccines. However, when vaccines formulated with these adjuvants are frozen or lyophilized, losses of efficacy are often reported. This loss of potency is usually attributed to the aggregation of adjuvant parti...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical sciences Vol. 97; no. 6; pp. 2049 - 2061
Main Authors Clausi, Amber L., Merkley, Scott A., Carpenter, John F., Randolph, Theodore W.
Format Journal Article
LanguageEnglish
Published Hoboken Elsevier Inc 01.06.2008
Wiley Subscription Services, Inc., A Wiley Company
Wiley
American Pharmaceutical Association
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aluminum-salt adjuvants are widely used to increase immunogenicity of recombinant protein vaccines. However, when vaccines formulated with these adjuvants are frozen or lyophilized, losses of efficacy are often reported. This loss of potency is usually attributed to the aggregation of adjuvant particles during processing. In this study, we examine the aggregation behavior of Alhydrogel™, a commercial aluminum hydroxide adjuvant, during freeze-thawing and freeze-drying. By cooling Alhydrogel™ formulations at faster rates or by the addition of sufficient amounts of a glass forming excipient such as trehalose, aggregation of Alhydrogel™, can be prevented or minimized. We propose that freeze-concentration of buffer salts induces modifications in adjuvant surface chemistry and crystallinity, which in turn favor aggregation. These modifications, and the resulting aggregation of Alhydrogel™ particles can be minimized through choice of buffer ions, or kinetically inhibited by rapidly forming a glassy state during freezing.
Bibliography:ArticleID:JPS21143
ark:/67375/WNG-QSKQDX94-2
istex:B38CAD15DE079522EA53E2F2874657B92FC40E80
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-3549
1520-6017
DOI:10.1002/jps.21143